Possibility of the reversal of multidrug resistance and the avoidance of side effects by liposomes modified with MRK-16, a monoclonal antibody to P-glycoprotein-Reference-Cited by-同舟云学术

Possibility of the reversal of multidrug resistance and the avoidance of side effects by liposomes modified with MRK-16, a monoclonal antibody to P-glycoprotein

Published:2001-11 Issue:1-2 Volume:77 Page:77-86
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Matsuo Hirotami,Wakasugi Masahiro,Takanaga Hitomi,Ohtani Hisakazu,Naito Mikihiko,Tsuruo Takashi,Sawada Yasufumi

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference26 articles.

1. Positively charged liposomes containing tumor necrosis factor in solid tumors;Yasui;Biol. Pharm. Bull.,2000

2. Liposomal daunorubicin: in vitro and in vivo efficacy in multiple myeloma;Pratt;Hematol. Oncol.,1998

3. Selective targeting of immunoliposomal doxorubicin against human multiple myeloma in vitro and ex vivo;Lopes de Menezesal;Biochim. Biophys. Acta,2000

4. Targeted gene transfer for adenocarcinoma using a combination of tumor-specific antibody and tissue-specific promoter;Kurane;Jpn. J. Cancer Res.,1998

5. P-Glycoprotein drug efflux pump involved in the mechanisms of intrinsic drug resistance in various colon cancer cell lines. Evidence for a saturation of active daunorubicin transport;Spoelstra;Biochem. Pharmacol.,1991

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiolipin for Enhanced Cellular Uptake and Cytotoxicity of Thermosensitive Liposome-Encapsulated Daunorubicin toward Breast Cancer Cell Lines;International Journal of Molecular Sciences;2022-10-04

2. Treating primary lymphoma of the brain in AIDS patients via multifunctional oral nanoparticulate systems;Nanomedicine;2022-03

3. Recent Advancements of Stimuli-Responsive Targeted Liposomal Formulations for Cancer Drug Delivery;Pharmaceutical Nanotechnology;2022-02

4. Liposome Nanocarriers for Peptide Drug Delivery;Peptide Therapeutics;2022

5. The reversal of chemotherapy-induced multidrug resistance by nanomedicine for cancer therapy;Journal of Controlled Release;2021-07